Primary tumor resection versus systemic therapy alone in patients with colorectal cancer and unresectable distant metastases: a systematic review and meta-analysis

Abstract Background The role of primary tumor resection (PTR) in patients with colorectal cancer (CRC) and unresectable distant metastases remains controversial. While PTR may prevent tumor-related complications, it delays systemic therapy and carries surgical risks. This systematic review and meta-analysis synthesizes evidence from randomized controlled trials (RCTs) comparing PTR followed by systemic therapy versus systemic therapy alone. Methods This systematic review was registered with PROSPERO (registration number CRD42024533819) and conducted according to PRISMA 2020 guidelines. We searched PubMed, Cochrane Library, CINAHL, Scopus, and Google Scholar on August 6, 2024 for RCTs comparing PTR plus systemic therapy versus systemic therapy alone in patients with CRC and unresectable metastases. Study selection and data extraction were performed independently by two reviewers. Risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB 2) tool. Meta-analyses were performed using random-effects models for overall survival (OS), mortality, and delayed PTR rates. Heterogeneity was assessed using I² statistics. Results Five RCTs comprising 1,122 patients were included. Meta-analysis of four studies ( n = 1,074) showed no significant difference in OS between PTR plus systemic therapy and systemic therapy alone (pooled HR 0.87, 95% CI 0.69–1.10, p = 0.15, I²=44%). Mortality analysis of three studies ( n = 409) demonstrated a non-significant trend toward higher mortality with PTR (pooled RR 1.78, 95% CI 0.67–4.73, I²=36%). Delayed PTR in the chemotherapy-alone arm occurred in 8% of patients (95% CI 3–18%, I²=79%). Conclusions Current evidence from RCTs does not support routine PTR in asymptomatic or minimally symptomatic patients with CRC and unresectable metastases. Systemic therapy alone appears to have acceptable rates of tumor-related complications.

Authors

Publication Details

Journal
Langenbeck s Archives of Surgery
Published
2026-10-08
DOI
https://doi.org/10.1007/s00423-026-04305-x
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Primary tumor resection versus systemic therapy alone in patients with colorectal cancer and unresectable distant metastases: a systematic review and meta-analysis

Karthik Prakash, Mufaddal Khuzema Kazi, Abdeali Saif Arif Kaderi
Langenbeck s Archives of Surgery
Colorectal Cancer Treatments and Studies
article

Primary tumor resection versus systemic therapy alone in patients with colorectal cancer and unresectable distant metastases: a systematic review and meta-analysis

Karthik Prakash, Mufaddal Khuzema Kazi, Abdeali Saif Arif Kaderi
article en

Abstract

Abstract Background The role of primary tumor resection (PTR) in patients with colorectal cancer (CRC) and unresectable distant metastases remains controversial. While PTR may prevent tumor-related complications, it delays systemic therapy and carries surgical risks. This systematic review and meta-analysis synthesizes evidence from randomized controlled trials (RCTs) comparing PTR followed by systemic therapy versus systemic therapy alone. Methods This systematic review was registered with PROSPERO (registration number CRD42024533819) and conducted according to PRISMA 2020 guidelines. We searched PubMed, Cochrane Library, CINAHL, Scopus, and Google Scholar on August 6, 2024 for RCTs comparing PTR plus systemic therapy versus systemic therapy alone in patients with CRC and unresectable metastases. Study selection and data extraction were performed independently by two reviewers. Risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB 2) tool. Meta-analyses were performed using random-effects models for overall survival (OS), mortality, and delayed PTR rates. Heterogeneity was assessed using I² statistics. Results Five RCTs comprising 1,122 patients were included. Meta-analysis of four studies ( n = 1,074) showed no significant difference in OS between PTR plus systemic therapy and systemic therapy alone (pooled HR 0.87, 95% CI 0.69–1.10, p = 0.15, I²=44%). Mortality analysis of three studies ( n = 409) demonstrated a non-significant trend toward higher mortality with PTR (pooled RR 1.78, 95% CI 0.67–4.73, I²=36%). Delayed PTR in the chemotherapy-alone arm occurred in 8% of patients (95% CI 3–18%, I²=79%). Conclusions Current evidence from RCTs does not support routine PTR in asymptomatic or minimally symptomatic patients with CRC and unresectable metastases. Systemic therapy alone appears to have acceptable rates of tumor-related complications.

Langenbeck s Archives of Surgery
Openalex Percentile: Top 16%
Colorectal Cancer Treatments and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Primary tumor resection versus systemic therapy alone in patients with colorectal cancer and unresectable distant metastases: a systematic review and meta-analysis — Karthik Prakash, Mufaddal Khuzema Kazi, et al. · Langenbeck s Archives of Surgery (2026) | TGRS Research Map | TGRS